A. S. Pendyukhova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. S. Pendyukhova has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Natalia L. Belkova
Scientific centre for Family Health and Human Reproduction Problems
4 shared publications - Natalia Viktorovna Semenova
Scientific centre for Family Health and Human Reproduction Problems
4 shared publications - Lyubov Vladimirovna Rychkova
Scientific centre for Family Health and Human Reproduction Problems
3 shared publications - Elizaveta S. Klimenko
Scientific centre for Family Health and Human Reproduction Problems
2 shared publications - Nadezhda Smurova
Scientific centre for Family Health and Human Reproduction Problems
2 shared publications - R. E. Zugeeva
Scientific centre for Family Health and Human Reproduction Problems
2 shared publications
Latest Publications
- Open Access
- 30 May 2026
- Published by IMR Press in Frontiers in Bioscience-Elite
- Vol. 18 (2) , 47162
Lactobacillus paragasseri lg94 With High L-Lactic Acid Production and Probiotic Potential
Background: Lactobacillus paragasseri strains are widely used as probiotics. According to modern requirements, it is necessary to characterize their morphological, cultural, physiological-biochemical, and antagonistic properties, as well as to determine their virulence, toxigenicity, toxicity, and secondary metabolite production, to study their potential and safety. The main aim of the study was to determine the probiotic potential of the L. paragasseri lg94 strain based on its biochemical features and genomic landscape. Methods: L. paragasseri lg94 was isolated from human feces. The genus and species were determined by mass spectrometry using the MALDI Biotyper. The main cultural, biochemical, and genomic characteristics of L. paragasseri lg94 were established. The biochemical profile and L-lactic acid content of the strain were determined. Additionally, the strain’s resistance to bile and low pH stress, as well as its antibiotic susceptibility, were assessed. The genomic sequence of strain lg94 was obtained using Illumina NextSeq550 sequencing. Results: In this study, the strain lg94 isolated from the feces of a healthy child was identified as L. paragasseri. After 24 h of cultivation in API 50 CH/CHL medium, strain lg94 exhibited positive results in the fermentation of 25 carbohydrates. Strain lg94 exhibited intense L-lactic acid production, reaching a concentration of 6.41 g/L in 24 h of cultivation, indicating high acid-forming capacity. The results showed that L. paragasseri lg94 demonstrated low resistance to acid stress (pH 2.0) but high resistance to 0.3% bile, with no changes in colony morphology observed. The disk diffusion assay revealed that L. paragasseri lg94 was phenotypically susceptible to several antibiotics, including ampicillin, amoxicillin, penicillin G, tetracycline, erythromycin, and chloramphenicol, with intermediate resistance to oxacillin and resistance to fosfomycin, gentamicin, and clindamycin. The whole-genome of L. paragasseri lg94 was sequenced. The absence of antibiotic resistance, pathogenicity, and virulence determinants in the genome was confirmed. Strain lg94 has genes for the production of gassericin T, enterolysin A, and helveticin J. Conclusions: The results of the studies showed that L. paragasseri lg94 has probiotic potential, and it is recommended to continue studying its antagonistic activity and secondary metabolite production.
- 30 May 2026
- Published by IMR Press in Frontiers in Bioscience-Elite
- Vol. 18 (2) , 47162
Open AccessLactobacillus paragasseri lg94 With High L-Lactic Acid Production and Probiotic Potential
Background: Lactobacillus paragasseri strains are widely used as probiotics. According to modern requirements, it is necessary to characterize their morphological, cultural, physiological-biochemical, and antagonistic properties, as well as to determine their virulence, toxigenicity, toxicity, and secondary metabolite production, to study their potential and safety. The main aim of the study was to determine the probiotic potential of the L. paragasseri lg94 strain based on its biochemical features and genomic landscape. Methods: L. paragasseri lg94 was isolated from human feces. The genus and species were determined by mass spectrometry using the MALDI Biotyper. The main cultural, biochemical, and genomic characteristics of L. paragasseri lg94 were established. The biochemical profile and L-lactic acid content of the strain were determined. Additionally, the strain’s resistance to bile and low pH stress, as well as its antibiotic susceptibility, were assessed. The genomic sequence of strain lg94 was obtained using Illumina NextSeq550 sequencing. Results: In this study, the strain lg94 isolated from the feces of a healthy child was identified as L. paragasseri. After 24 h of cultivation in API 50 CH/CHL medium, strain lg94 exhibited positive results in the fermentation of 25 carbohydrates. Strain lg94 exhibited intense L-lactic acid production, reaching a concentration of 6.41 g/L in 24 h of cultivation, indicating high acid-forming capacity. The results showed that L. paragasseri lg94 demonstrated low resistance to acid stress (pH 2.0) but high resistance to 0.3% bile, with no changes in colony morphology observed. The disk diffusion assay revealed that L. paragasseri lg94 was phenotypically susceptible to several antibiotics, including ampicillin, amoxicillin, penicillin G, tetracycline, erythromycin, and chloramphenicol, with intermediate resistance to oxacillin and resistance to fosfomycin, gentamicin, and clindamycin. The whole-genome of L. paragasseri lg94 was sequenced. The absence of antibiotic resistance, pathogenicity, and virulence determinants in the genome was confirmed. Strain lg94 has genes for the production of gassericin T, enterolysin A, and helveticin J. Conclusions: The results of the studies showed that L. paragasseri lg94 has probiotic potential, and it is recommended to continue studying its antagonistic activity and secondary metabolite production.
- Open Access
- 23 September 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (4) , 113-120
A pilot in vitro study of the antagonistic properties of Lactiplantibacillus plantarum isolates derived from the intestines of healthy adolescents in the Irkutsk region
Background. The growing antibiotic resistance; complicating the treatment of intestinal dysbiosis and related diseases; makes the development of probiotics for microbiota correction increasingly relevant. Lactiplantibacillus plantarum exhibits probiotic potential due to its antagonistic activity. Considering the strain-specific nature of this property; studying local isolates of L. plantarum is necessary for creating new; more effective probiotic preparations.The aim. To evaluate the in vitro antagonistic properties of five isolates of L. plantarum isolated from the intestines of healthy adolescents in the Irkutsk region against multidrug-resistant isolates of opportunistic bacteria and Escherichia coli.Materials and methods. Five isolates of L. plantarum 43p; 45p; 46p; 52p; and 57p were used; 25 multidrug-resistant isolates of opportunistic bacteria representing the species Enterobacter hormaechei; E. cloacae; Klebsiella pneumoniaе; K. oxytoca; K. variicola; Pseudomonas aeruginosa; Staphylococcus aureus; Citrobacter amalonaticus; and 23 isolates of E. coli with different characteristics. Antagonistic activity was evaluated by methods of perpendicular strokes and the well diffusion method.Results. L. plantarum isolates showed statistically significant variations in antagonistic activity; and these variations were also dependent on the testing method. A lot more activity was seen with the perpendicular strokes method. Statistically significant differences (p < 0.05) indicated that isolates 43p; 45p; and 46p were more effective antagonists than 52p and 57p; irrespective of the method. A marked antagonistic effect of L. plantarum isolates 43p; 45p; and 46p was observed against P. aeruginosa.Conclusion. This pilot study confirmed the strain-specific antagonistic potential of L. plantarum against multidrug-resistant opportunistic bacteria and E. coli; identifying L. plantarum isolates 43p; 45p; and 46p as the most promising candidates. These findings support the need for further screening of L. plantarum isolates; as well as other Lactobacillus species; cultured from the normal microbiota of healthy adolescents in the Irkutsk region. Furthermore; investigation of the mechanisms of antagonism is warranted to develop novel; effective probiotics based on local isolates.
- 23 September 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (4) , 113-120
Open AccessA pilot in vitro study of the antagonistic properties of Lactiplantibacillus plantarum isolates derived from the intestines of healthy adolescents in the Irkutsk region
Background. The growing antibiotic resistance; complicating the treatment of intestinal dysbiosis and related diseases; makes the development of probiotics for microbiota correction increasingly relevant. Lactiplantibacillus plantarum exhibits probiotic potential due to its antagonistic activity. Considering the strain-specific nature of this property; studying local isolates of L. plantarum is necessary for creating new; more effective probiotic preparations.The aim. To evaluate the in vitro antagonistic properties of five isolates of L. plantarum isolated from the intestines of healthy adolescents in the Irkutsk region against multidrug-resistant isolates of opportunistic bacteria and Escherichia coli.Materials and methods. Five isolates of L. plantarum 43p; 45p; 46p; 52p; and 57p were used; 25 multidrug-resistant isolates of opportunistic bacteria representing the species Enterobacter hormaechei; E. cloacae; Klebsiella pneumoniaе; K. oxytoca; K. variicola; Pseudomonas aeruginosa; Staphylococcus aureus; Citrobacter amalonaticus; and 23 isolates of E. coli with different characteristics. Antagonistic activity was evaluated by methods of perpendicular strokes and the well diffusion method.Results. L. plantarum isolates showed statistically significant variations in antagonistic activity; and these variations were also dependent on the testing method. A lot more activity was seen with the perpendicular strokes method. Statistically significant differences (p < 0.05) indicated that isolates 43p; 45p; and 46p were more effective antagonists than 52p and 57p; irrespective of the method. A marked antagonistic effect of L. plantarum isolates 43p; 45p; and 46p was observed against P. aeruginosa.Conclusion. This pilot study confirmed the strain-specific antagonistic potential of L. plantarum against multidrug-resistant opportunistic bacteria and E. coli; identifying L. plantarum isolates 43p; 45p; and 46p as the most promising candidates. These findings support the need for further screening of L. plantarum isolates; as well as other Lactobacillus species; cultured from the normal microbiota of healthy adolescents in the Irkutsk region. Furthermore; investigation of the mechanisms of antagonism is warranted to develop novel; effective probiotics based on local isolates.
- Open Access
- 23 July 2024
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 9 (3) , 121-129
Antagonistic activity of monocultures and consortia of lactobacilli against multidrug-resistant isolates of opportunistic bacteria as a screening of their probiotic potential
Background. In recent years, special attention has been paid to the studying the consortia of probiotic bacteria. In these associations, the properties of individual microorganisms can be enhanced, in particular, their antagonistic activity which is an effective indicator for screening of probiotic potential. The development of probiotics based on such consortia with antibacterial properties is critical in the light of the growing problem of drug resistance in microorganisms.The aim of the work. To study the antagonistic activity of monocultures and consortia of lactobacilli against multidrug-resistant isolates of opportunistic bacteria. Materials and methods. The antagonistic activity of lactobacilli monocultures and their consortia was assessed simultaneously by two methods: the cross streak method and the well diffusion method.Results. All strains of lactobacilli and their consortia, depending on the research method, had varying degrees of antagonistic activity. Five consortia had stronger antagonism to test cultures as compared to monocultures, while in one consortium, the effect of antagonistic activity was reduced compared to monocultures. The results of studying the antagonistic activity of two consortia (Limosilactobacillus fermentum 44/1 and Lacticaseibacillus rhamnosus 12L, Latilactobacillus curvatus LCR-111-1 and Lactiplantibacillus plantarum 8PAZ) contradict data on the biocompatibility of strains in these consortia. Differences in the degree of antagonistic effects of lactobacilli on gram-positive and gram-negative species of opportunistic bacteria were revealed.Conclusion. The study showed that both the biocompatibility of the probiotic strains and the antagonistic activity of the consortium are the important requirements for creating a probiotic consortium with effective probiotic potential. To study the antagonistic properties of lactobacilli, the number of isolates of target gram-positive and gram-negative bacteria and normobiota should be increased. This will allow us to determine effective strategies for using probiotics in conditions of the spread of drug resistance of microorganisms.
- 23 July 2024
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 9 (3) , 121-129
Open AccessAntagonistic activity of monocultures and consortia of lactobacilli against multidrug-resistant isolates of opportunistic bacteria as a screening of their probiotic potential
Background. In recent years, special attention has been paid to the studying the consortia of probiotic bacteria. In these associations, the properties of individual microorganisms can be enhanced, in particular, their antagonistic activity which is an effective indicator for screening of probiotic potential. The development of probiotics based on such consortia with antibacterial properties is critical in the light of the growing problem of drug resistance in microorganisms.The aim of the work. To study the antagonistic activity of monocultures and consortia of lactobacilli against multidrug-resistant isolates of opportunistic bacteria. Materials and methods. The antagonistic activity of lactobacilli monocultures and their consortia was assessed simultaneously by two methods: the cross streak method and the well diffusion method.Results. All strains of lactobacilli and their consortia, depending on the research method, had varying degrees of antagonistic activity. Five consortia had stronger antagonism to test cultures as compared to monocultures, while in one consortium, the effect of antagonistic activity was reduced compared to monocultures. The results of studying the antagonistic activity of two consortia (Limosilactobacillus fermentum 44/1 and Lacticaseibacillus rhamnosus 12L, Latilactobacillus curvatus LCR-111-1 and Lactiplantibacillus plantarum 8PAZ) contradict data on the biocompatibility of strains in these consortia. Differences in the degree of antagonistic effects of lactobacilli on gram-positive and gram-negative species of opportunistic bacteria were revealed.Conclusion. The study showed that both the biocompatibility of the probiotic strains and the antagonistic activity of the consortium are the important requirements for creating a probiotic consortium with effective probiotic potential. To study the antagonistic properties of lactobacilli, the number of isolates of target gram-positive and gram-negative bacteria and normobiota should be increased. This will allow us to determine effective strategies for using probiotics in conditions of the spread of drug resistance of microorganisms.
- Open Access
- 27 September 2023
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 8 (4) , 20-31
Probiotic consortiums: Structure and antagonistic activity against opportunistic bacteria and human normobiota (using the example of Escherichia coli) in vitro
Background. Using probiotic preparations based on consortia of microorganisms not only helps to restore the balance of the intestinal microbiota, but also increases the therapeutic effect of probiotics. Promising sources for obtaining probiotic consortia are milk products that have undergone natural fermentation with the help of spontaneously formed microbial consortia. The aim. To study the structure of five microbial consortia with probiotic properties from naturally fermented milk products and to assess in vitro their antagonistic activity against opportunistic bacteria and a representative of the human normobiota – Escherichia coli. Materials and methods. The structure of bacterial consortia was analyzed by sequencing methods. The antagonistic activity of the consortia was assessed by the disk diffusion method. Results. It has been established that the studied microbial consortiums are represented by Enterococcus spp. and Streptococcus spp. bacteria. In consortiums No. 1, No. 2, and No. 3, Enterococcus bacteria dominated, while in consortiums No. 4 and No. 5, Streptococcus dominated. Antagonistic activity was shown against four isolates of opportunistic bacteria: Klebsiella pneumoniae No. 493, Enterobacter hormaechei No. 372, Staphylococcus aureus No. 4 and Pseudomonas aeruginosa No. 25 IMB, as well as against one representative of the human normobiota – Escherichia coli No. 495. The highest growth delay zone is found in E. coli No. 495 isolate. Three test cultures (K. pneumoniae No. 509, E. coli ATCC25922 and P. aeruginosa No. 3 IMB) exhibited more dense growth around probiotic consortia. Conclusion. The results of the study showed that the effect of probiotic consortia differing in the composition of microorganisms can be neutral and bactericidal. The presence of antagonistic activity in the studied microbial consortia against multiresistant isolates of opportunistic bacteria is a prospect for creating probiotics with antibacterial properties.
- 27 September 2023
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 8 (4) , 20-31
Open AccessProbiotic consortiums: Structure and antagonistic activity against opportunistic bacteria and human normobiota (using the example of Escherichia coli) in vitro
Background. Using probiotic preparations based on consortia of microorganisms not only helps to restore the balance of the intestinal microbiota, but also increases the therapeutic effect of probiotics. Promising sources for obtaining probiotic consortia are milk products that have undergone natural fermentation with the help of spontaneously formed microbial consortia. The aim. To study the structure of five microbial consortia with probiotic properties from naturally fermented milk products and to assess in vitro their antagonistic activity against opportunistic bacteria and a representative of the human normobiota – Escherichia coli. Materials and methods. The structure of bacterial consortia was analyzed by sequencing methods. The antagonistic activity of the consortia was assessed by the disk diffusion method. Results. It has been established that the studied microbial consortiums are represented by Enterococcus spp. and Streptococcus spp. bacteria. In consortiums No. 1, No. 2, and No. 3, Enterococcus bacteria dominated, while in consortiums No. 4 and No. 5, Streptococcus dominated. Antagonistic activity was shown against four isolates of opportunistic bacteria: Klebsiella pneumoniae No. 493, Enterobacter hormaechei No. 372, Staphylococcus aureus No. 4 and Pseudomonas aeruginosa No. 25 IMB, as well as against one representative of the human normobiota – Escherichia coli No. 495. The highest growth delay zone is found in E. coli No. 495 isolate. Three test cultures (K. pneumoniae No. 509, E. coli ATCC25922 and P. aeruginosa No. 3 IMB) exhibited more dense growth around probiotic consortia. Conclusion. The results of the study showed that the effect of probiotic consortia differing in the composition of microorganisms can be neutral and bactericidal. The presence of antagonistic activity in the studied microbial consortia against multiresistant isolates of opportunistic bacteria is a prospect for creating probiotics with antibacterial properties.